APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More
Our client is interested in hearing from clients who wish to change the site of manufacturing and package the following dosage forms; Tablets, Capsules, Effervescent tablets and Liquid injections. More
Displaying 11..15 of 15 -
per page
Previous page
Order by